Imaging in early stage cervical cancer

Autor: Hoogendam, JP

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::bdb1093d78caac6b994326c393d0b372
https://dspace.library.uu.nl/handle/1874/345862

Oncological outcome and long-term complications in robot-assisted radical surgery for early stage cervical cancer: an observational cohort study.

Autor: Hoogendam, JP, Verheijen, RHM, Wegner, I, Zweemer, RP

Publikováno v: BJOG: An International Journal of Obstetrics & Gynaecology; Nov2014, Vol. 121 Issue 12, p1538-1545, 8p

Introducing a novice surgeon to an experienced robotic gynaecological oncology team: An observational cohort study on the impact of a structured curriculum on outcomes of cervical cancer surgery.

Autor: Baeten IGT; Department of Gynaecological Oncology, Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. Electronic address: i.g.t.baeten@umcutrecht.nl., Hoogendam JP; Department of Gynaecological Oncology, Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Schreuder HWR; Department of Gynaecological Oncology, Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Jürgenliemk-Schulz IM; Department of Radiology and Nuclear Medicine, Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Gerestein CG; Department of Gynaecological Oncology, Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Zweemer RP; Department of Gynaecological Oncology, Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2023 Nov; Vol. 178, pp. 153-160. Date of Electronic Publication: 2023 Oct 19.

Lymphocele following lymph node dissection in cervical and endometrial cancer: A systematic review and meta-analysis.

Autor: Jansen A; Department of Gynecologic Oncology, Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., de Jong A; Department of Gynecologic Oncology, Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Hoogendam JP; Department of Gynecologic Oncology, Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Baeten IGT; Department of Gynecologic Oncology, Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Jürgenliemk-Schulz IM; Department of Radiation Oncology, Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Zweemer RP; Department of Gynecologic Oncology, Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Gerestein CG; Department of Gynecologic Oncology, Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. Electronic address: C.G.Gerestein-2@umcutrecht.nl.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2023 Mar; Vol. 170, pp. 273-281. Date of Electronic Publication: 2023 Feb 02.

Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testing.

Autor: Bokkers K; Department of Genetics, Division Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands., Bleiker EMA; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Family Cancer Clinic, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Clinical Genetics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Hoogendam JP; Department of Gynecological Oncology, University Medical Center Utrecht, Heidelberglaan 100, PO Box 85500, 3584 CX, Utrecht, The Netherlands., Velthuizen ME; Department of Genetics, Division Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands., Schreuder HWR; Department of Gynecological Oncology, University Medical Center Utrecht, Heidelberglaan 100, PO Box 85500, 3584 CX, Utrecht, The Netherlands., Gerestein CG; Department of Gynecological Oncology, University Medical Center Utrecht, Heidelberglaan 100, PO Box 85500, 3584 CX, Utrecht, The Netherlands.; Department of Gynecology, Meander Medical Center, Maatweg 3, 3813 TZ, Amersfoort, The Netherlands., Lange JG; Department of Gynecology, St. Antonius Hospital, Koekoekslaan 1, 3435 CM, Nieuwegein, the Netherlands., Louwers JA; Department of Gynecology, Diakonessenhuis, Bosboomstraat 1, 3582 KE, Utrecht, The Netherlands., Koudijs MJ; Department of Genetics, Division Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands., Ausems MGEM; Department of Genetics, Division Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands., Zweemer RP; Department of Gynecological Oncology, University Medical Center Utrecht, Heidelberglaan 100, PO Box 85500, 3584 CX, Utrecht, The Netherlands. R.Zweemer@umcutrecht.nl.

Publikováno v: Hereditary cancer in clinical practice [Hered Cancer Clin Pract] 2022 Sep 08; Vol. 20 (1), pp. 33. Date of Electronic Publication: 2022 Sep 08.